
Welcome to Dishman Carbogen Amcis Ltd!
We are a global outsourcing partner for pharmaceutical companies, offering a portfolio of products and development, scale-up and manufacturing services. The Dishman Group continually invests in the pharmaceutical industry, ensuring our businesses can provide pharmaceutical customers with high-value, high-quality products and services today and in the future. Our focus is to add value to the global pharmaceutical industry by serving as a reliable partner. We strongly believe that our business is successful only when our customers are successful.
The mission of Dishman Carbogen Amcis Ltd and its fundamental purpose is to offer support and assistance to people across the world suffering from illness and disease, striving to ensure that this is completed efficiently, comprehensively, and effectively.

Ahmedabad, Gujarat, INDIA – [11 June, 2026] – Dishman Carbogen Amcis Ltd (DCAL) has signed a Memorandum of Understanding (MoU) with IIT Gandhinagar under the institute’s Healthcare & MedTech Research Cluster (HMRC), launched on 11 June 2026.
DCAL has entered into a Memorandum of Understanding (MoU) with IIT Gandhinagar under the institute’s Healthcare & MedTech Research Cluster (HMRC), launched on 11 June 2026. This strategic partnership marks a significant step towards strengthening...


NEW DELHI, India, (April 18, 2024) – Dishman Carbogen Amcis Ltd received the Choose France-Best Indian Investment in France award by the Indo French Chamber of Commerce & Industry in partnership with Business France India, at the sixth flagship event of the Indo-French Business Awards (IFBA) and Grand Prix VIE, in New Delhi. His Excellency Mr. Thierry Mathou, Ambassador of France presented the award which recognises Dishman’s investment in a new...

Gujarat, India - After a successful on-site inspection, Ahmedabad-based Dishman Carbogen Amcis Ltd (DCAL), receives the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) certification.
DCAL’s drug substances manufacturing facility located in Bavla, underwent an inspection by the Japanese Health Authority. We are glad to announce that the inspection ended satisfactorily, and no major or critical observations...

Gujarat, INDIA (March 2024) – Ahmedabad-based Dishman Carbogen Amcis Ltd (DCAL), a pharmaceutical API manufacturing and drug development company receives the USFDA certification after a successful inspection of its manufacturing facility in Bavla.
The inspection conducted by the United States Food and Drug Administration (US FDA) at Dishman Carbogen Amcis Ltd's facility in Bavla, Ahmedabad, which was scheduled from March 4 to March 8, 2024, was successfully...

Dishman Carbogen Amcis Ltd granted CEP by EDQM and EUDRA GMP Certification by the Italian Medicines Agency
Gujarat, INDIA (January 2024) – Ahmedabad-based Dishman Carbogen Amcis Ltd (DCAL), a pharmaceutical API manufacturing and drug development company receives the CEP certification by the EDQM and the EUDRA GMP by the Italian...
© 2025 Dishman Carbogen Amcis Ltd - All Rights Reserved